Dominykas Milašius, Delta Biosciences CEO
Geopolitical strategist turned deep tech entrepreneur & investor. Building and field-testing a proprietary drug candidate screening platform.
LIFE SCIENCES
We are building and field-testing a proprietary drug candidate screening platform, powered by a powerful combination of the latest bench science advances: microdroplet sorting, DNA-encoded libraries and next-generation sequencing.
Dominykas is investment partner at Baltic Sanbox Venture too. Latest achievements:
* 300 applications funnelled down into ±1.2M EUR invested into 12 DeepTech deals.
* 1st acceleration cohort completed, and the 2nd launched (±10 more deals incoming!)
* 3 incubation programs with top LT unies delivered, and a Life Sciences focused four-partner program launched this Monday.
Current businesses: Delta Biosciences | Balticsandbox.ventures
